G

GI Innovation Inc
KOSDAQ:358570

Watchlist Manager
GI Innovation Inc
KOSDAQ:358570
Watchlist
Price: 10 030 KRW -4.11% Market Closed
Market Cap: 443.5B KRW
Have any thoughts about
GI Innovation Inc?
Write Note

Relative Value

The Relative Value of one GI Innovation Inc stock under the Base Case scenario is 13 081.31 KRW. Compared to the current market price of 10 030 KRW, GI Innovation Inc is Undervalued by 23%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
13 081.31 KRW
Undervaluation 23%
Relative Value
Price
G
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
31
vs Industry
15
Median 3Y
114.7
Median 5Y
114.7
Industry
7.7
Forward
2.2
vs History
vs Industry
Median 3Y
-9.3
Median 5Y
-9.3
Industry
22.7
Forward
2
vs History
vs Industry
Median 3Y
-12.4
Median 5Y
-12.4
Industry
21.6
vs History
vs Industry
Median 3Y
-12
Median 5Y
-12
Industry
25.2
vs History
4
vs Industry
9
Median 3Y
7.2
Median 5Y
7.2
Industry
2.5
vs History
27
vs Industry
12
Median 3Y
106.3
Median 5Y
106.3
Industry
7.7
Forward
2.1
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9
vs History
vs Industry
Median 3Y
-9.6
Median 5Y
-9.6
Industry
4.2
Forward
3.1
vs History
vs Industry
Median 3Y
-9
Median 5Y
-9
Industry
4.1
Forward
3.2
vs History
vs Industry
Median 3Y
-11.6
Median 5Y
-11.6
Industry
5.7
vs History
vs Industry
Median 3Y
-11.4
Median 5Y
-11.4
Industry
3.6
vs History
4
vs Industry
17
Median 3Y
13.2
Median 5Y
13.2
Industry
4.6

Multiples Across Competitors

Competitors Multiples
GI Innovation Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
GI Innovation Inc
KOSDAQ:358570
443.3B KRW 93.2 -9.5 -10.7 -9.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 888 840.5 -180 080 -218 674.5 -216 179.2
US
Abbvie Inc
NYSE:ABBV
314.7B USD 5.7 61.9 15.4 23.7
US
Amgen Inc
NASDAQ:AMGN
157B USD 4.8 37.1 17.4 32.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.2B USD 4 890.3 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 859.4 -474.5 -516.7 -502.9
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 6 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.9 -54.9 -59 -53.2
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.6 -130.6 -105.1 -76.6
P/E Multiple
Earnings Growth
KR
G
GI Innovation Inc
KOSDAQ:358570
Average P/E: 208
Negative Multiple: -9.5
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 080 N/A
US
Abbvie Inc
NYSE:ABBV
61.9
412%
US
Amgen Inc
NASDAQ:AMGN
37.1
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
890.3
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -474.5 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.9 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -130.6 N/A
EV/EBITDA Multiple
EBITDA Growth
KR
G
GI Innovation Inc
KOSDAQ:358570
Average EV/EBITDA: 17.2
Negative Multiple: -10.7
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 674.5 N/A
US
Abbvie Inc
NYSE:ABBV
15.4
28%
US
Amgen Inc
NASDAQ:AMGN
17.4
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
38%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -516.7 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.1 N/A
EV/EBIT Multiple
EBIT Growth
KR
G
GI Innovation Inc
KOSDAQ:358570
Average EV/EBIT: 22.5
Negative Multiple: -9.9
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 179.2 N/A
US
Abbvie Inc
NYSE:ABBV
23.7
88%
US
Amgen Inc
NASDAQ:AMGN
32.9
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -502.9 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.6 N/A

See Also

Discover More
Back to Top